非洲抗逆转录病毒治疗项目中失访患者的结局:个体患者数据Meta分析
该研究为系统综述与个体患者数据Meta分析,纳入9项追踪失访患者的研究、共7377例在撒哈拉以南非洲启动联合抗逆转录病毒治疗(cART)后失访的患者。末次就诊4年后,21.8%已知死亡、22.6%存活但停止cART、14.8%静默转诊、9.2%仍在cART中、31.6%未找到。作者认为评估项目结局和UNAIDS目标时须考虑失访者死亡,并建议立即启动cART和早期追踪失访者。
要点
- 失访患者末次就诊4年后21.8%已知死亡,31.6%未能找到。
- 22.6%存活但停止cART,14.8%静默转诊,仅9.2%仍在cART中。
- 死亡与男性、疾病更晚期、cART疗程更短相关。
核心结论
- 评估撒哈拉以南非洲项目结局和UNAIDS目标时,必须考虑失访患者的死亡。
- 作者建议将立即启动cART和早期追踪失访患者作为优先事项。
研究设计与样本
- 系统综述与个体患者数据Meta分析,纳入9项追踪失访患者的研究。
- 共纳入7377例在撒哈拉以南非洲启动cART后失访的患者,启动cART时中位CD4计数为129 cells/μL。
主要发现
- 末次就诊4年后,21.8%(95%CI 20.8%-22.7%)已知死亡。
- 末次就诊4年后,22.6%(95%CI 21.6%-23.6%)存活但停止cART。
- 末次就诊4年后,14.8%(95%CI 14.0%-15.6%)转至其他诊所,9.2%(95%CI 8.5%-9.8%)仍在cART中,31.6%(95%CI 30.6%-32.7%)未能找到。
- 死亡与男性、疾病更晚期和cART疗程更短相关;停止cART与疾病较不晚期和cART疗程更长相关;静默转诊与女性和疾病较不晚期相关。
临床怎么用
- 作者建议将立即启动cART和早期追踪失访患者作为优先事项。
- 作者认为评估项目结局和UNAIDS目标时须考虑失访患者的死亡。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Low retention on combination antiretroviral therapy (cART) has emerged as a threat to the Joint United Nations Programme on human immunodeficiency virus (HIV)/AIDS (UNAIDS) 90-90-90 targets. We examined outcomes of patients who started cART but were subsequently lost to follow-up (LTFU) in African treatment programs. METHODS: This was a systematic review and individual patient data meta-analysis of studies that traced patients who were LTFU. Outcomes were analyzed using cumulative incidence functions and proportional hazards models for the competing risks of (i) death, (ii) alive but stopped cART, (iii) silent transfer to other clinics, and (iv) retention on cART. RESULTS: Nine studies contributed data on 7377 patients who started cART and were subsequently LTFU in sub-Saharan Africa. The median CD4 count at the start of cART was 129 cells/μL. At 4 years after the last clinic visit, 21.8% (95% confidence interval [CI], 20.8%-22.7%) were known to have died, 22.6% (95% CI, 21.6%-23.6%) were alive but had stopped cART, 14.8% (95% CI, 14.0%-15.6%) had transferred to another clinic, 9.2% (95% CI, 8.5%-9.8%) were retained on cART, and 31.6% (95% CI, 30.6%-32.7%) could not been found. Mortality was associated with male sex, more advanced disease, and shorter cART duration; stopping cART with less advanced disease andlonger cART duration; and silent transfer with female sex and less advanced disease. CONCLUSIONS: Mortality in patients LTFU must be considered for unbiased assessments of program outcomes and UNAIDS targets in sub-Saharan Africa. Immediate start of cART and early tracing of patients LTFU should be priorities.
引用
- Chammartin F, Zürcher K, Keiser O, et al. Outcomes of Patients Lost to Follow-up in African Antiretroviral Therapy Programs: Individual Patient Data Meta-analysis. Clin Infect Dis. 2018. PMID: 29889240. doi:10.1093/cid/ciy347
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。